Researchers at the University of Auckland in New Zealand are creating an ice cream to help combat the side effects of chemotherapy, reports Reuters.

Called ReCharge, this "medical dessert" uses active ingredients from dairy products to relieve diarrhea, anemia and lack of appetite in cancer patients undergoing chemotherapy.

Auckland researchers are conducting a trial where participants are being asked to eat 100 grams (a little over 3.5 ounces) of the strawberry-flavored ice cream every day for eight weeks, starting two weeks prior and for the first six weeks of chemotherapy.

A spokesperson from dairy giant Fonterra, which is helping to produce the ice cream, tells Reuters that two bio-active milk components show potential in helping the body cope with chemotherapy side effects.

The NY Daily News says ReCharge could be the first ice cream you need a prescription to buy if it goes on market.